Crane NXT (CXT) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Jul, 2026Executive summary
Achieved sales growth of 20% in Q4 and 11.4% for the full year, driven by acquisitions and strong performance in currency and authentication businesses.
Adjusted EBITDA margin reached 25% in Q4 and 24% for the year; Adjusted EPS was $1.27 in Q4 and $4.06 for the year.
Secured 20 new currency denomination wins using micro-optics technology and completed key equipment upgrades for the new U.S. currency series.
Completed acquisition of De La Rue Authentication and initial equity investment in Antares Vision, with full acquisition and privatization expected by mid-2026.
Raised annual dividend by 6% and declared a Q1 2026 dividend of $0.18 per share.
Financial highlights
Q4 sales were $477 million, up 20% year-over-year; full-year sales reached $1.7 billion, up 11.4%.
Q4 adjusted EPS was $1.27; full-year adjusted EPS was $4.06; adjusted free cash flow conversion was 135% in Q4 and 94% for the year.
Net leverage ended at 2.3x; total debt rose to $1,139.5M at year-end.
Cash provided by operating activities was $241.5M; adjusted free cash flow was $221.8M, up 19% year-over-year.
Adjusted EBITDA for 2025 was $402.7M (24.3% margin).
Outlook and guidance
2026 sales growth expected at 4%-6%, with high single-digit growth in Security & Authentication and flat CPI segment.
Adjusted EPS guidance for 2026 is $4.10-$4.40; adjusted EBITDA margin projected at 25%-28%.
Adjusted free cash flow conversion expected between 90%-110% in 2026.
CapEx for currency to rise to 7% of revenue in 2026, with total company CapEx at 3%-5% of sales.
Full-year guidance includes full-year contribution from De La Rue and anticipated consolidation of Antares Vision.
Latest events from Crane NXT
- Record backlog, margin expansion, and ambitious 2028 targets drive a strong outlook.CXT
Oppenheimer 29th Annual Technology, Internet & Communications Conference - Q2 2026 sales rose 22% with raised EPS guidance, record backlogs, and margin expansion.CXT
Q2 2026 - Board and auditor approvals passed; strong 2025 results and growth-focused 2026 outlook shared.CXT
AGM 2026 - Sales up 17% year-over-year, Adjusted EPS $0.60, and full-year sales guidance raised to 15%-17%.CXT
Q1 2026 - Board recommends electing nine directors, auditor ratification, and approving executive pay.CXT
Proxy filing - Targets ~$2.5B revenue and $600M EBITDA by 2028 through growth, M&A, and innovation.CXT
Investor Day 2026 - Acquisition expands into regulated growth markets with strong synergies and financial upside.CXT
M&A Announcement - Q1 2025 sales up 5.3% to $330.3M; full-year sales growth guidance raised to 6–8%.CXT
Q1 2025 - 2024 results met expectations; 2025 outlook sees modest growth, margin headwinds, and ongoing diversification.CXT
Q4 2024